Results 201 to 210 of about 43,089 (386)

Heart Failure with Reduced Ejection Fraction (HFrEF) and Preserved Ejection Fraction (HFpEF): The Diagnostic Value of Circulating MicroRNAs [PDF]

, 2019
Yei‐Tsung Chen, Lee Lee Wong, Oi Wah Liew, Mark Richards   +3 more
openalex   +1 more source

Potential effects of beta-blockers in HFpEF

Heart Failure Reviews
Abstract Heart failure with preserved ejection fraction (HFpEF) poses a significant challenge in contemporary medicine, characterized by poor quality of life, high healthcare costs, and increased mortality. Despite advancements in medical research, treatment strategies for HFpEF remain elusive, with unclear guidance on the use of beta ...
Tokarczyk, Wojciech, Urban, Szymon, Patrzałek, Patryk, Stolarski, Łukasz, Iwanek, Gracjan, Szymański, Oskar, Zymliński, Robert   +6 more
openaire   +2 more sources

Clinical endpoints in pragmatic heart failure trials: From data collection to clinical endpoint classification

ESC Heart Failure, EarlyView.
Abstract Clinical endpoint classification (CEC)—that is, evaluation of clinical events using pre‐defined criteria—is commonly conducted in clinical trial operations to ensure systematic and consistent assessment of endpoints needed to assess the intervention's safety and efficacy.
Veraprapas Kittipibul, Harriette G.C. Van Spall, William Schuyler Jones, Marat Fudim, Robert J. Mentz, Kevin Anstrom, Bertram Pitt, Patrice Desvigne‐Nickens, Jerome L. Fleg, Camilla Hage, Stefan James, Claes Held, Lars Lund, Adam DeVore   +13 more
wiley   +1 more source

Metabolic Syndrome Nonalcoholic Steatohepatitis Male Mouse With Adeno‐Associated Viral Renin as a Novel Model for Heart Failure With Preserved Ejection Fraction

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Heart failure with preserved ejection fraction (HFpEF) currently accounts for more than half of patients with HF, with limited approved evidence‐based therapies.
Yuji Shi, Patricia Perez‐Bonilla, Xian Chen, Kelly Tam, Mackenzie Marshall, Jeffrey Morin, Brianna LaViolette, Nouaying R. Kue, Federico Damilano, Russell A. Miller, Bei B. Zhang, Rachel J. Roth Flach, Dinesh Hirenallur‐Shanthappa   +12 more
doaj   +1 more source

Myocardial phenotypes and dysfunction in HFpEF and HFrEF assessed by echocardiography and cardiac magnetic resonance [PDF]

, 2019
B Berlot, Chiara Bucciarelli‐Ducci, Alberto Palazzuoli, Paolo Marino   +3 more
openalex   +1 more source

Prognostic value of nutritional status in patients with heart failure with preserved ejection fraction, with and without atrial fibrillation: insights From PURSUIT-HFpEF Registry [PDF]

, 2020
Masato Kawasaki, T Yamada, Tetsuya Watanabe, Takashi Morita, Yoichi Furukawa, Shunsuke Tamaki, A Kikuchi, Tsutomu Kawai, Mi Hae Seo, Masatake Fukunami, Y Yasumura, Takaharu Hayashi, Masamichi Yano, Shungo Hikoso, Yasuhiko Sakata   +14 more
openalex   +1 more source

Prediction of functional capacity by the HFA-PEFF score in patients with acute decompensated heart failure with preserved ejection fraction: a post-hoc analysis from the PURSUIT-HFpEF registry [PDF]

, 2021
Katsuomi Iwakura, Toshinari Onishi, Yohei Sotomi, Masato Okada, Yasushi Koyama, Atsunori Okamura, Shunsuke Tamaki, Masamichi Yano, Takaharu Hayashi, Takahisa Yamada, Yoshio Yasumura, Kenshi Fujii, Shungo Hikoso, Yasushi Sakata   +13 more
openalex   +1 more source

Nephrological perspectives on the underutilization of SGLT2is in heart failure and chronic kidney disease

ESC Heart Failure, Volume 12, Issue 2, Page 1490-1491, April 2025.
Özant Helvacı, Ömer Faruk Akçay, Emre Yaşar, Ülver Derici, Galip Güz   +4 more
wiley   +1 more source

Atrial‐secondary tricuspid regurgitation: a better prognosis in early stage heart failure, but not in late stage

ESC Heart Failure, EarlyView.
Atrial TR as more favourable prognosis except in advanced patients. Abstract Background and Aims Although the classification of secondary tricuspid regurgitation (STR) by atrial or ventricular aetiology (A‐STR or V‐STR) carries prognostic importance, the confounding effects of New York Heart Association (NYHA) class have not yet been elucidated.
Corentin Bourg, K. Charlotte Lee Frost, Augustin Coisne, Elizabeth Curtis, Guillaume L'official, Yoan Lavie‐Badie, Léo Lemarchand, Julien Dreyfus, Emmanuel Oger, Erwan Donal   +9 more
wiley   +1 more source

Myocardial Proteome in Human Heart Failure With Preserved Ejection Fraction

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Heart failure with preserved ejection fraction (HFpEF) constitutes more than half of all HF but has few effective therapies. Recent human myocardial transcriptomics and metabolomics have identified major differences between HFpEF and controls.
Vivek P. Jani, Edwin J. Yoo, Aleksandra Binek, Alina Guo, Julie S. Kim, Jennifer Aguilan, Mohammad Keykhaei, Sydney R. Jenkin, Simone Sidoli, Kavita Sharma, Jennifer E Van Eyk, David A. Kass, Virginia S. Hahn   +12 more
doaj   +1 more source